Product Images Sensorcaine(r) (bupivacaine Hci And Epinephrine)

This is a medication used for infiltration and nerve block procedures only. It should not be used for caudal, epidural, or spinal anesthesia. The medication contains sulfites and should be stored at a temperature between 20 and 25 degrees Celsius. The injection should not be used if it appears pinkish or darker than slightly yellow or if it contains a precipitate. The usual dosage is indicated in the insert, and the package comes with warnings and instructions. The medication was manufactured in Mukiteo, WA 98275 by HF Acquisition Co, LLC.*

SENSORCAINE™ with Epinephrine 1:200,000 (as bitartrate) is a medication packaged in a 50mL vial with a concentration of 5mg/mL. It is intended for infiltration and nerve blocks only, and is not to be used for caudal, epidural, or spinal anesthesia. This medication contains sulfites and the usual dosage can be found in the provided insert. It should be stored at 20°C to 25°C (68°F to 77°F) and protected from light. Autoclaving is not recommended, and the injection should not be used if the color is darker than slightly yellow or if it contains a precipitate. This medication is only available with a prescription and more information can be found in the manufacturer’s package insert. The NDC number is 6332346157 and it is manufactured by HE Acquisition Co. in Washington state.*

This appears to be a table outlining the recommended concentrations of anesthesia and the related motor blocks one can expect from each dosage. The table includes information on different types of block administration, including local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, and dental. The table lists several percentages, ranging from 0.25% to 0.75%, and varying doses in mL and mg. Depending on the type of block, the motor block can be complete, moderate, or partial.*

This is a list of product codes, units of sale, and strengths for various medications. The medications come in single-dose vials of various sizes and are packaged in trays or packs of 5. The strengths are listed per mL and per vial.*

This text provides information regarding product codes and unit of sale for a medication, which is available in different strengths. The medication is available in 50mL multiple trays of 25 vials with varying strengths of 125mg, 250mg, 2.5mg per mL, and 5mg per mL, with NDC codes mentioned for each strength. Additionally, two percentages - 0.25% and 0.50% - of medication strength are also mentioned.*

This text provides a list of different types and concentrations of anesthesia used for various procedures such as local infiltration, nerve block, retrobulbar block, epidural, caudal, and dental block. It also includes specific percentages and variations with epinephrine for each anesthetic type mentioned.*

This is a list of various drug classes and examples of drugs that fall under them. The drug classes include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. Examples of drugs under each class are provided, such as nitric oxide and nitroglycerin under nitrates/nitrites, articaine and lidocaine under local anesthetics, and chloroquine under antimalarials.*

This is a description of a medical product labeled as Sensorcain with 0.25% Bupivacaine HCI and USP with Epinephrine injection for infiltration and nerve block. The NDC code is 63323-461-57 and the product ID is 6120940. It is not recommended for caudal, epidural, or spinal anesthesia sites and contains sulfite. It is a 90 mL multiple dose vial produced by HF Acquisition in Mukilteo, WA.*

The 0.75% concentration of Sensorcaine injection is not recommended for obstetrical anesthesia due to reports of cardiac arrest and death during use of Bupivacaine for epidural anesthesia in obstetrical patients. The 0.75% concentration should be reserved for surgical procedures where a high degree of muscle relaxation and prolonged effect are necessary. Local anesthetics should only be employed by well-versed clinicians who have the necessary treatment resources including cardiopulmonary resuscitative equipment, and the correct personnel to manage any acute emergencies. Mixing or the prior or intercurrent use of any local anesthetic with Bupivacaine is not recommended due to insufficient data on the clinical use of such mixtures. Bupivacaine with Epinephrine 1:200,000 should not be used concomitantly with ergot-type oxytocic drugs, and solutions of Bupivacaine containing a vasoconstrictor, such as epinephrine, should be used with extreme caution in patients receiving monoamine oxidase inhibitors. Lastly, Bupivacaine is not recommended for use in intravenous regional anesthesia (Bier Block) because there have been reports of cardiac arrest and death during its use.*